To prescribe or supply a Schedule 8 cannabis medicine in NSW, the prescriber must:
The TGA has an online system to apply for authorisation to prescribe or supply unregistered cannabis medicines under the Special Access Scheme (SAS). This online system is available on the TGA.
Prescribers are encouraged to use the TGA’s online system for SAS applications.
The Poisons and Therapeutic Goods Act 1966 sets the controls on the prescribing and supply of Schedule 8 cannabis medicines in NSW. To prescribe or supply a Schedule 8 cannabis medicine, an application to NSW Health is required in certain circumstances. These are where:
Prescribers are encouraged to use the TGA’s online system for SAS applications to NSW to prescribe or supply unregistered Schedule 8 cannabis medicines as this provides a streamlined application pathway. This online system is available on the TGA.
A medical practitioner must submit an application directly to NSW Health:
The form Application for Authority to Prescribe or Supply a Schedule 8 Cannabis Medicine for Human Therapeutic Use is to be used in these circumstances.
A NSW Authority is not required in the following circumstances:
To apply for a NSW Authority to prescribe or supply an unregistered Schedule 8 cannabis medicine for the purpose of a clinical trial, the form Application for Authority to Prescribe or Supply a Substance for the Purpose of Human Research is to be used.
Information about clinical trials is available on National Health and Medical Research Council - Australian clinical trials. For further information on prescribing or supplying cannabis medicines, please contact Pharmaceutical Regulatory Unit by email at MOH-PharmaceuticalServices@health.nsw.gov.au or on (02) 9391 9944.
Information about prescribing or supplying extemporaneously compounded Schedule 8 medicines or unregistered Schedule 8 medicines other than cannabis medicines is available.
Alternative text: Pathways for registered and unregistered Schedule 8 cannabis medicines under the Special Access Scheme.
Alternative text: Authorised Prescriber and Clinical Trial pathways for Schedule 8 cannabis medicines.
For more information, visit prescribing compounded medicines.
Fact sheet for medical practitioners - Legal access to cannabis based medicines.